We tapped Sandeep Samudre, PhD, MPH, to lead our trial operations including the pivotal trial for knee osteoarthritis and other efforts in our pipeline across…
Dr. Manish Gupta, an orthopaedic surgeon with a sports medicine focus enters as GID BIO’s newest principal investigator in a pivotal trial of the GID SVF-2…
GID BIO welcomes two new employees to the team as the newest of eight trial sites begin gearing up to enroll patients to participate in…
Tariq Awan, DO, a double-certified family and sports medicine physician with a special focus in sports medicine enters as GID BIO’s newest principal investigator in a pivotal Phase III trial evaluating cellular therapy for the treatment…
New trial site, the University of Pittsburgh Medical Center, joins GID BIO’s pivotal Phase III trial…
Charles De Mesa, DO, MPH, a Northern California practicing specialist in anesthesiology and pain medicine, physical medicine and rehabilitation and musculoskeletal pain medicine is GID Bio’s newest principal investigator in a pivotal trial…
OrthoCarolina, GID BIO’s newest trial site, is led by Dr. Claude T. Moorman III as principal investigator. Dr. Moorman is a sports medicine surgeon at OrthoCarolina’s Sports Medicine Center; the president of Atrium Health’s Musculoskeletal Institute; and Chair of Atrium Health’s Department of Orthopaedic Surgery…
Neil Sparks, DO, MS, a North Carolina physician specializing in the comprehensive primary and musculoskeletal care of children, adults and families, is the newest principal investigator in GID BIO’s pivotal trial…
LOUISVILLE, Colo. and PITTSBURGH, Aug. 18, 2020 — Following FDA clearance of an expanded access protocol to treat a small group of COVID-19 patients using the GID BIO technology platform, The Richard King Mellon Foundation has awarded $250,000 to GID BIO to conduct the study for patients with severe respiratory distress due to COVID-19…
LOUISVILLE, Colo., July 28, 2020 — Roy J. Bostock, former Chairman of Yahoo!, Vice Chairman of Delta Airlines and a director of Morgan Stanley, has joined the cellular medicine startup GID BIO…
